MetrionAIResearch

Sign in Register

Home Watchlist Market News High Impact News Market Movers Screener Portfolio Calculators Heatmap Compare Calendars Crypto Forex Macro Maps

Research Tools

Financial Analysis Analyst Estimates Insider Trading Market Guide Trading Ideas Charts

Financial Analysis

Highlights Income Statement Balance Sheet Cash Flow Multiples Profitability

Loading market dashboard

My Watchlist

Sign in to track securities

Create an account to keep a persistent watchlist.

Home High Impact News Market Movers

Loading stock research

Defence Therapeutics Inc.

DTC.CN

HealthcareCNQCA

Sign in to save

CA$0.52

+CA$0.02 (+4.00%)

Overview Financials Analysis Valuation Thesis Ownership Compare AI Report News

DTC.CN

1Y+0.02 (+4.00%)

Candles, volume, SMA 20, and SMA 50

O 0.52H 0.52L 0.52C 0.52Date Jun 9

DTC.CN

SMA 20 SMA 50 Vol 14.00KEEarnings dates

Open in Chartsfor further analysis

Business Description

Open for the full company profile when you need deeper context.

ShowHide

Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a biotechnology company founded in 2017. This firm focuses on pioneering biological and biosimilar therapeutic solutions for both cancer and infectious diseases. A cornerstone of its approach is the exclusive ACCUM™ technology, engineered to precisely and safely transport vaccine antigens or antibody-drug conjugates (ADCs) directly to their intended cellular targets. The company's development efforts span several key areas: novel dendritic cell vaccines for various cancers, protein-based vaccines addressing COVID-19 and other infectious ailments, and specialized antibody-drug conjugate products aimed at different cancer types. Defence Therapeutics Inc. adopted its current name in March 2020, having previously operated as Accum Therapeutics Inc.

Key Metrics

Quick size, liquidity, and volatility measures for the stock.

Market Cap?$29.83M

Volume?14.00K

Avg Volume?43.43K

52w RangeCA$0.435 - CA$0.93

Beta?1.40

Price Performance

1M

+4.0%

CA$0.50 to CA$0.52

YTD

-27.8%

CA$0.72 to CA$0.52

1Y

-35.0%

CA$0.80 to CA$0.52

3Y

-80.0%

CA$2.60 to CA$0.52

5Y

-90.9%

CA$5.69 to CA$0.52

10Y

N/A

history unavailable

Company Details

CEO, industry, employees, IPO date, currency, and website.

ShowHide

CEOSebastien Plouffe

IndustryBiotechnology

Employees5

IPO Date2021-05-10

CurrencyCAD

Websitedefencetherapeutics.com

Related stocks

Check out other names from the same Biotechnology industry as DTC.CN.

BriaCell Therapeutics Corp.

The Cannabist Company Holdings Inc.

Gemina Laboratories Ltd.

Microbix Biosystems Inc.

Resverlogix Corp.

Telescope Innovations Corp.

Theralase Technologies Inc.